1. Home
  2. CMRE vs INBX Comparison

CMRE vs INBX Comparison

Compare CMRE & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$15.27

Market Cap

1.9B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$110.27

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
INBX
Founded
1974
2010
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2010
2024

Fundamental Metrics

Financial Performance
Metric
CMRE
INBX
Price
$15.27
$110.27
Analyst Decision
Hold
Buy
Analyst Count
1
3
Target Price
$12.00
$150.00
AVG Volume (30 Days)
341.2K
328.0K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
550.00
52 Week Low
$10.84
$26.19
52 Week High
$18.06
$155.29

Technical Indicators

Market Signals
Indicator
CMRE
INBX
Relative Strength Index (RSI) 45.41 51.54
Support Level $13.86 $70.23
Resistance Level $15.86 $131.01
Average True Range (ATR) 0.46 10.16
MACD -0.04 -1.30
Stochastic Oscillator 15.25 43.91

Price Performance

Historical Comparison
CMRE
INBX

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: